Kestra Medical Technologies (KMTS) stock

Wearable medical devices , market cap $1.7B

Wearable medical devices

Worth $1.7B

$29.55

-1.89%

As of Tuesday's close · Live for Pro members at the open

Quality Score

Above Average

In its industry

#20of 84

Medical Devices

Checks firing

7of 14

Trending up

From 52-week high

-7.4%

under its best in a year

KMTS's Quality Score fell 1 point on Tue, Nov 10, to 12. Buying slipped from its highest in 20 days (2 chart checks stopped).

See KMTS's 14 chart checksSee it live, free until Thursday morning. No account. No card. Then keep going with a free account.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Key facts on KMTS

Key facts on KMTS
The chart	Above every average
Latest filing	10-Q, Sep 14 Filed its quarterly report (10-Q) for the quarter to Jul 31, 2026

1 more reason behind KMTS's 12, free with an account →6 more reasons behind KMTS's 12, for Pro members.

What's next

Wed Nov 11: Stifel Healthcare Conference 2026Investor conference · date confirmed.

2 more dates ahead: conferences, for Pro members.

KMTS catalysts

Coming up

After its last 4 reports it closed +1.0% on average, higher 3 of 4 times.

Why KMTS scores 12

Above Averagefor quality, not price, 7 of 14 chart checks firingWhat the Quality Score means

+7Chart checks 7 of 14 firing right now, one point each
+4Long-term trend above a rising 200-⁠day average, near its 52-⁠week high, at a multi-⁠year high

Run-up adds
Profit subtractsRead on the last four quarters against the four before, or the last full year where no quarters are filed.
Growth addsSales and margins against a year earlier: up to +3 for fast growth and widening margins, down to -2 when both shrink.
Dilution subtractsNew shares over the year: -1 at 10% more, -2 at 25% more.
Volatility subtractsA daily range of 5% or more with nothing behind it (no profit or cash flow, sales shrinking, or 10% more shares outstanding with no free cash flow): -1, or -2 from 8%.
Cash flow subtracts-1 when free cash flow over the last four quarters is negative.
Persistence adds

No effect today: Size, News, and Insider trades.

What every line is worth, and the reason behind it, on KMTS and every other stock.Get in free →

Price, score, chart checks, and the industry rank are from a snapshot taken at 10:56 PM ET, at least 15 minutes behind. How we rank stocks.

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

Alert me when KMTS's Quality Score turns up

A free account. No card.

How KMTS ranks in Medical Devices

KMTS is #20 of 84 by Quality Score.

How KMTS ranks in Medical Devices
Rank	Stock	Checks	Quality Score
1	DCTHDelcath Systems	7/14	22
2	EWEdwards Lifesciences	7/14	19
3	WSTWest Pharmaceutical Services	7/14	18
	ISRGIntuitive Surgical		Open for its score
	KIDSOrthoPediatrics		Open for its score
	LIVNLivaNova		Open for its score
	LMATLeMaitre Vascular		Open for its score
20	KMTSKestra Medical	7/14	12

When does KMTS report earnings, and what happens after?

Expected to report Mon Dec 14, after the close (in 34 days).

What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.

What KMTS reported on Sep 14, 2026

The quarter

The figures are not read from the release yet.

“The increase was primarily attributable to growth in expenses related to the company's commercial expansion and accelerated investment in key R&D programs.”

The filing on EDGAR

Where the sales came from

KMTS's results filing gives no sales by line in a table we read.

The outlook

The outlook the company gave, by period
Measure	Figure
FY27
Revenue	$141Mraised

Figures as filed (SEC filing, Sep 14)

The numbers

Market value: $1.7B; today
Sales: $107M; up 60.7% on the year
Free cash flow: -$123M; last 12 months

3 more figures, for Pro members.

No analyst estimates on Breakaway: every figure here is filed.

The whole report on KMTS: every line of its sales, every outlook beside the one it replaced, and the company's words, for Pro members.

Close after the report, last 3

-7.4%+1.8%+4.7%

Mar 17Jul 14Sep 14

Reported	When	Gap	Reaction	5 days
Sep 14, 2026After close	After close	-9.0%	+4.7%	+3.0%
Jul 14, 2026After close	After close	-0.3%	+1.8%	-8.0%
Mar 17, 2026After close	After close	0.0%	-7.4%	-2.1%

KMTS closed higher after 3 of its last 4 reports.

All 4 reports, and KMTS's Quality Score going into each

KMTS sales and profit by year

Sales and profit by year

Sales grew every year from 2024 to 2026, to $95.1M. It lost money in each of the three years.

KMTS has 7 of 14 chart checks firing

Trend1 of 5 shown

MA FAN 21 EMA W.EMA HH/HL 52W HI

Volume1 of 3 shown

VOL VDU U/D VOL

Tight range1 of 3 shown

ATR SQZ SQUEEZE NR7

Buying1 of 3 shown

OBV+CLOSE HI SPRING

The other 10 checks on KMTS, and all 14 on every stock.Get in free →

KMTS RSI today: 54.1, above its 50-day and 200-day averages

Not scored

RSI 54.1, MACD below signal, above both averages. Not scored.13 readings

The deep dive on KMTS

What it does and how it makes money3 findingsAn operating loss of $135M in fiscal 2026, on $95.1M of sales.Annual report, filed Jul 14, 2026"Assuming all required fees and other charges are paid, the earliest expiry date for issued patents owned or used by us is in February 2031." (10-K for fiscal 2026)SEC filing · Jul 14, 2026
Where it stands6 findingsFor Pro members6 findings on where KMTS stands: its cash, debt, and share count, for Pro members
What changed in its filings1 finding"In addition, in the past, when the market price of a stock has been volatile, holders of that stock have sometimes instituted securities class action litigation against the company that issued the stock." (10-K for fiscal 2026)SEC filing · Jul 14, 2026
Who holds and trades it2 findingsFor Pro members2 findings on who holds and trades KMTS, for Pro members

9 more findings on KMTS, each with its source, for Pro members.

KMTS share count over time

Shares: 14.2% more than a year ago (to Jul 31).

Shares of KMTS outstanding, as filed
Shares outstanding	As of
59.6M	Sep 11, 2026
58.6M	Jul 9, 2026
58.4M	Mar 12, 2026
58.3M	Dec 5, 2025

Offerings, shelves, and splits of KMTS, from its filings
From its filings	Filed
Raised $138M in a sale of shares, about 8% of its market value	Dec 3, 2025

KMTS insider trades

11 insiders sold $4.8M across 27 filings in the last 6 months. No open-⁠market buys on record. The newest:

SellTimothy P. Moran$94KChief Business Officerat $29.56 on Nov 3, filed Nov 5

SellTimothy P. MoranChief Business Officer$94Kat $29.56 on Nov 3, filed Nov 5

All 27 insider filings on KMTS from the last six months, for Pro members.

All KMTS insider trades

KMTS's officers and directors

Officers and directors with a Form 4 in the last 12 months.

Vaseem MahboobChief Financial Officer · 8 trades
Brian Daniel WebsterOfficer · 16 trades
Traci S. UmbergerOfficer · 7 trades
Alfred J. Ford Jr.Chief Commercial Officer · 4 trades
Timothy P. MoranChief Business Officer · 4 trades
Raymond W. CohenDirector · 2 trades
Conor HanleyDirector · 1 trade
Elizabeth KwoDirector · 1 trade

2 more officers and directors file at KMTS.

See insider trades by person

About Kestra Medical Technologies

Kestra Medical Technologies Ltd is a commercial-stage wearable medical device and digital healthcare company focused on connected monitoring, therapeutic intervention, and data-driven clinical insights for cardiovascular disease. It has developed and is commercializing the Cardiac Recovery System platform, an integrated cardiac recovery ecosystem designed to support patients at elevated risk of sudden cardiac arrest (SCA) during vulnerable periods of recovery. The platform is anchored by the ASSURE Wearable Cardioverter Defibrillator (WCD), which continuously monitors patient heart rhythms and automatically delivers defibrillation therapy when life-threatening ventricular arrhythmias are detected. The platform also includes digital patient engagement and clinical workflow solutions.

443 employeesKirkland, WAkestramedical.com

Here is what Pro members see.

The same page for Pro members, on Microsoft
Its Quality Score and rank, the line that drives it, and the live price.
The full chart
A year of candles to start, out to the whole history, with insider trades marked and the Quality Score under the price.
Every line of the score
Price action, the company, and signals, each with its points, on KMTS and every other stock.
CEOs buying their own stock
Every CEO buy, biggest names first. Sort, filter, save the list, and set optional alerts.
Congress trades
A member's trades, newest first, each with its amount. Sort and filter the whole list.
14 chart checks, read for you
The ones firing on the stock, each in plain words, its rule a tap away.
Earnings, week by week
Who reports each day, and how each stock took its last four reports.
FDA dates, counted down
Each date in the company's words, its cash against the date, and an optional alert before it.
The market map
Every stock a box, colored by its Quality Score.
Themes, ranked live
Each theme's stocks ranked by Quality Score, live. Here, AI chips.
The top 10, every day
The ten highest Quality Scores at each close, kept day by day, week by week.
Optional alerts, your way
Pick a stock, a score, a price, a filing, or a whole scan. It tells you by push or email.
Your watchlist, scored
Your stocks by Quality Score, today's move, or name.
On your phone and your laptop
The same account and watchlist on both, each laid out for its screen.

Prices refresh every 2.5 seconds during market hours.
Optional alerts by push, email, or the bell.
Add it to your Home Screen and it opens like an app.

Pro members see every line of every stock's score.

What would move KMTS's score: 7 things
2 more filings explained, a plain line each
Real-⁠time prices, no delay

BreakawayNov 5Timothy P. Moran sold KMTS$94K at $29.56, filed Nov 5

Alerts are optional.

See KMTS's 14 chart checks

See it live, free until Thursday morning. No account. No card. Then keep going with a free account.

Straight AnswersStraight Answers

As of Nov 10, 2026: KMTS's Quality Score is 12 (Above Average), #20 of 84 in Medical Devices. Insiders sold $4.8M in the last 6 months (Form 4).

What does KMTS's Quality Score say?

KMTS scores 12 today, which Breakaway calls Above Average. It is #20 of 84 in Medical Devices by Quality Score, with 7 of 14 chart checks firing. Shares: 14.2% more than a year ago (to Jul 31). Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.

What is KMTS's Quality Score?

KMTS scores 12 today, which Breakaway calls Above Average (11 to 14). That is #20 of 84 in Medical Devices by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind KMTS's 12.

Are insiders buying KMTS?

11 insiders sold $4.8M across 27 filings in the last 6 months. No open-⁠market buys on record. The newest is Timothy P. Moran, Chief Business Officer, who sold $94K on Nov 3. Every filing, with the scored weight, for Pro members.

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.